Simultaneous Quantitation of a Novel α(1)/β(1)-Blocker TJ0711 and Its Two Metabolites in Dog Plasma Using LC-MS/MS and Its Application to a Pharmacokinetic Study after Intravenous Infusion

TJ0711∙HCl, which is a novel α(1)/β(1) adrenoceptor blocking agent with a ratio of 1:1 for α(1)/β(1), is designed to treat and prevent perioperative hypertension. M1 and M3 were identified as important metabolites in vitro for either antihypertension activity or the major metabolite production. In o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Wenwen, Liu, Wanyu, Li, Haojv, Xu, Guojia, Li, Qian, Huang, Jiangeng, Li, Gao, Si, Luqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359546/
https://www.ncbi.nlm.nih.gov/pubmed/30669292
http://dx.doi.org/10.3390/pharmaceutics11010038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359546/
https://www.ncbi.nlm.nih.gov/pubmed/30669292
http://dx.doi.org/10.3390/pharmaceutics11010038

Ejemplares similares